Lessons from basic research in selenium and cancer prevention.
about
sameAs
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancerDeterminants of selenium status in healthy adultsProstate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerStable isotope-resolved metabolomics and applications for drug developmentProduction of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferaseOsteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteineSe-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitroBiological Chemistry of Hydrogen SelenideRegulation of the extracellular antioxidant selenoprotein plasma glutathione peroxidase (GPx-3) in mammalian cellsProlonged dietary selenium deficiency or excess does not globally affect selenoprotein gene expression and/or protein production in various tissues of pigsSurvivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.Molecular and biochemical characterization of the selenocysteine Se-methyltransferase gene and Se-methylselenocysteine synthesis in broccoli.Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells.Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysisSelenized milk casein in the diet of BALB/c nude mice reduces growth of intramammary MCF-7 tumorsSelenium inhibition of survivin expression by preventing Sp1 binding to its promoterDifferential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefitIn vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men.Tumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of beta-catenin signaling.Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein.Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells.Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib.The expression of selenium-binding protein 1 is decreased in uterine leiomyomaThe selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2DSelenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.Reduction of splenic immunosuppressive cells and enhancement of anti-tumor immunity by synergy of fish oil and selenium yeastIdentification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS.XAS studies of Se speciation in selenite-fed rats.Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancerSelenium regulation of the selenoprotein and nonselenoprotein transcriptomes in rodentsThe Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology.Multilevel modeling and value of information in clinical trial decision support.Monitoring microarray-based gene expression profile changes in hepatocellular carcinomaMethylselenocysteine: a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugsSelenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma.
P2860
Q21134780-0B76AA33-18CD-4DDA-9E99-B0F768B4EA65Q21245924-82EFB438-734B-405A-9C73-C84D906556FEQ24306191-087754AF-9ECC-4FE9-8B2F-B97EDB89D339Q24629149-C8B7A9B2-0481-4043-AC8B-26AC0E596EA1Q24797066-BA211914-994A-4D33-8D47-71803246DF2EQ24806411-E7626916-387A-42DF-B522-8A318281BA24Q24813505-D36F39DB-5CE8-4292-9A9C-EDB3C18999A7Q28069453-B22FC63B-9F8C-483A-BCB6-8A6D54EFF154Q28116864-D34F82D0-B52E-4A93-BFF7-834B5AE51086Q30520447-7BC7AD7B-A9BD-4D20-85B0-1692CCF63D07Q30986928-6E490E37-E9EC-4660-861C-44FCCC2667E2Q33214571-8933AB95-FB68-44AD-BB11-8CDC6E3A7A75Q33326439-C6524FA3-7106-4891-A033-3E5584571109Q33475812-255B7ED8-AFEC-458D-8F93-46D6462FBA12Q33589383-1CFEA003-B643-49CE-827F-605C5251B5C5Q33652526-D04CF8D5-A5F5-44EE-BB92-6104CACB3A75Q33652577-27CD6F71-BB90-45F4-9F2C-40E8F8F51A67Q33657004-A1345AE5-1051-43E1-8561-B0A40AA15FB0Q33657012-4F9A2FFB-1AD8-48E0-8604-04F75A639A5CQ33681985-689B5A14-5B3B-4B48-A2CF-4BE252F72B74Q33688644-F8278875-FC01-4831-B9BD-54CE4CFF3D00Q33823652-A55319A4-0893-4A55-B7E6-21E2C6EBDCB5Q33981807-B5A49AB8-F660-4A63-B16A-CD6489F2BF17Q34042351-C2CC4E63-0497-4768-9C09-73732C97C6A7Q34249695-E8B3FBE0-BB6D-4092-9AC3-449EF59A254FQ34276889-E340EE0D-1115-483B-8267-8E853EA73CAEQ34417632-8063D81B-9462-417D-A06C-00328BE06FD5Q34461489-D2B91281-AFF5-42A8-8195-0880A3E3C86FQ34467682-5D50A50C-17B9-416F-9181-FF9A4915C2F2Q34500651-2C42AB3C-0F64-47F4-ADD5-3663937F9860Q34562117-4CC0A470-CA88-407A-A6BF-824FA2514639Q34571042-6CEAD7CF-A395-421A-AFB5-A7878765903EQ34573982-07A40B0A-876B-4FBF-BCEE-8A73E310FCC2Q34663140-FB5EF4F5-3544-4E76-887C-1AED08D413C6Q34729873-1339B67D-7880-422B-A6CD-117075E919D0Q34965687-35C54781-256F-486A-BBFF-0DA9F2EE853CQ35006548-F3FBC022-AF6F-4856-A72F-D4D24AEE028AQ35011295-78094D54-B28B-485D-BDA3-9EBBD145C08FQ35034404-CEB4DE40-7391-49E0-9267-D4CCAF85059DQ35144923-83DE870F-6918-4CAF-89F2-388151DF7825
P2860
Lessons from basic research in selenium and cancer prevention.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Lessons from basic research in selenium and cancer prevention.
@ast
Lessons from basic research in selenium and cancer prevention.
@en
Lessons from basic research in selenium and cancer prevention.
@nl
type
label
Lessons from basic research in selenium and cancer prevention.
@ast
Lessons from basic research in selenium and cancer prevention.
@en
Lessons from basic research in selenium and cancer prevention.
@nl
altLabel
Lessons from Basic Research in Selenium and Cancer Prevention
@en
Lessons from Basic Research in Selenium and Cancer Prevention
@nl
prefLabel
Lessons from basic research in selenium and cancer prevention.
@ast
Lessons from basic research in selenium and cancer prevention.
@en
Lessons from basic research in selenium and cancer prevention.
@nl
P356
P1433
P1476
Lessons from Basic Research in Selenium and Cancer Prevention
@en
Lessons from basic research in selenium and cancer prevention.
@en
P304
P356
10.1093/JN/128.11.1845
P407
P577
1998-11-01T00:00:00Z